<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Aguilera EC</submitter><funding>Biodroga Nutraceuticals</funding><funding>Biodroga Nutraceuticals Inc.</funding><pagination>5347</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9783836</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(24)</volume><pubmed_abstract>There is a growing interest for curcuminoids in the general population and the scientific research community. Curcuminoids, derived from turmeric spice, are lipophiles and therefore have a low solubility in water which hence have a low bioavailability in the human plasma. To circumvent this issue, a natural product developed by Biodroga Nutraceuticals combined curcuminoids with omega-3 fatty acids (OM3) esterified in monoglycerides (MAG). The objective was to perform a 24 h pharmacokinetics in humans receiving a single dose of curcuminoid formulated by three different means, and to compare their plasma curcuminoids concentration. Sixteen males and fifteen females tested three formulations: 400 mg of curcuminoids powder extract, 400 mg of curcuminoids in rice oil and 400 mg of curcuminoids </pubmed_abstract><journal>Nutrients</journal><pubmed_title>Comparative Pharmacokinetic of Curcuminoids Formulations with an Omega-3 Fatty Acids Monoglyceride Carrier: A Randomized Cross-Over Triple-Blind Study.</pubmed_title><pmcid>PMC9783836</pmcid><funding_grant_id>N/A</funding_grant_id><pubmed_authors>Aguilera EC</pubmed_authors><pubmed_authors>Vachon A</pubmed_authors><pubmed_authors>Plourde M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparative Pharmacokinetic of Curcuminoids Formulations with an Omega-3 Fatty Acids Monoglyceride Carrier: A Randomized Cross-Over Triple-Blind Study.</name><description>There is a growing interest for curcuminoids in the general population and the scientific research community. Curcuminoids, derived from turmeric spice, are lipophiles and therefore have a low solubility in water which hence have a low bioavailability in the human plasma. To circumvent this issue, a natural product developed by Biodroga Nutraceuticals combined curcuminoids with omega-3 fatty acids (OM3) esterified in monoglycerides (MAG). The objective was to perform a 24 h pharmacokinetics in humans receiving a single dose of curcuminoid formulated by three different means, and to compare their plasma curcuminoids concentration. Sixteen males and fifteen females tested three formulations: 400 mg of curcuminoids powder extract, 400 mg of curcuminoids in rice oil and 400 mg of curcuminoids </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-22T21:36:46.116Z</modification><creation>2024-11-12T21:18:57.11Z</creation></dates><accession>S-EPMC9783836</accession><cross_references><pubmed>36558506</pubmed><doi>10.3390/nu14245347</doi></cross_references></HashMap>